Corporate Actions

Ardelyx Inc. (NASDAQ: ARDX) has outlined strong growth prospects for its IBSRELA and XPHOZAH products, with IBSRELA and XPHOZAH both expected to exceed $500 million in revenue by 2026. This robust growth is attributed to strategic investments in sales, marketing, and R&D.

The Marex Group plc, a leading player in the Financial Services sector, has achieved record profit growth, expanding margins, and strategic M&A drive robust, resilient performance. Amid volatile market conditions, the company has demonstrated consistent profit growth andMarket Sharegains.

In a strong indication of its ongoing growth momentum, Ollie's Bargain Outlet Holdings Inc. (Nasdaq: OLLI) posted impressive Q1 2026 earnings results. According to the company's recent announcement, OLLI saw substantial earnings growth, 14% sales increase, and margin expansion, despite the headwinds posed by …

Amazon, theE-commerceand technology giant, has claimed the top spot in the Fortune 500 rankings, surpassing Walmart as the largest company by revenue. This marks a notable shift in the retail landscape, where Amazon's onlineBusinessmodel has enabled it to expand and diversify its offerings.

VEON Ltd (Nasdaq: VEON) will release its second-quarter earnings on July 31, 2026, providing investors with valuable insight into the company's performance. This key date marks a crucial moment in the financial calendar, as investors and analysts closely monitor VEON's progress.

Micron Technology Inc. (NASDAQ: MU) has broken through the $1 trillion market value milestone, solidifying its position as a leader in the memory chip industry. This comes amidst a growing demand for high-bandwidth memory (HBM) semiconductors, particularly in the AI sector.

Sera Prognostics Inc. (NASDAQ: SERA) has accelerated its commercial focus following strong PRIME study results, extending its cash runway through 2029. This shift marks a significant milestone for the company, which has concentrated on clinical development in the past.